Sanjivani Paranteral Ltd Q3 FY26 earnings call summary

Earnings call of 16 Feb 2026, summarised by AI from the filing.

Sanjivani Paranteral Q3 FY26 consolidated revenue ₹22.1 cr, up 27.1%; FY27 base business revenue guided at ₹90 cr.

Key takeaways

1. Consolidated revenue Q3 FY26 consolidated revenue ₹22.1 cr, a growth of 27.1% year-on-year, driven by base business and Pune subsidiary.
2. Growth driver Injectables to drive growth, especially with commercialization of IV facility expanding product basket.
3. Margin risk Product mix shifts quarter-to-quarter, so margins may vary, though general trajectory is upward.

Original filing on BSE

Sanjivani Paranteral Ltd earnings call, investor presentation and press release summaries

• Q1 FY27: Results deck (14 Aug 2026), Results press release (14 Aug 2026)
• Q4 FY26: Earnings call (15 May 2026), Results deck (14 May 2026)
• Q3 FY26: Earnings call (16 Feb 2026), Results deck (13 Jan 2026), Results press release (16 Feb 2026)
• Q2 FY26: Earnings call (19 Nov 2025), Results deck (18 Nov 2025), Results press release (15 Nov 2025)
• Q1 FY26: Earnings call (12 Aug 2025), Results deck (12 Aug 2025), Results press release (12 Aug 2025)
• Q4 FY25: Earnings call (27 May 2025), Results press release (27 May 2025)
• Q3 FY25: Results deck (27 Feb 2025)